The PCSK9 longevity gene- therapeutics, heart health, brain health, and supplements This post is the 7th in my series about longevity genes. The story of PCSK9 (proprotein convertase subtilisin/kexin type 9) is one of the most remarkable examples of translational medicine in

Stanford's AI Longevity Course starting Tuesday, in person or online. Still time to register: 1.⁠ ⁠Stanford AI Longevity Course starting on Tuesday: https://t.co/1O4jA1US56 @aubreydegrey @StanfordMed @Stanford

📢 Join the R42 Demo Day (online, from 16:00 UK time today): 🔹 Game42 at 16:15 🔹 Movie42 at 16:40 🔹 Author42 at 18:45 🔗 https://t.co/ZHK4dhTFM3 #R42xcapAI #CPAI #capAI #AI

Great to see @RonjonNag presenting today at the Unicorn Summit in Lisbon showcasing capAI and R42 amongst founders, investors and tech innovators looking to ignite the next generation of unicorns! #CPAI #AI #R42xCPAI #Unicorns https://t.co/wte2Cw3PcZ

We are very pleased to announce the immediate appointment of @RonjonNag as an adviser to the Company prior to joining the Board as an Executive Director on 1 April 2025. https://t.co/5USgpvE5ay #CPAI #AI

https://t.co/qKhQl9HZu7

Thanks @superbioai for including DiffDock on your platform!

⁦@RonjonNag⁩ #BayArea #update on a big week in the Silicon. Alley.

Europe’s University spin outs ‘On average Universities take 12.8% upon founding — and that figure’s dramatically skewed by the average of 19.8% in the UK, against 7.3% in mainland Europe’

Accelerating #ML for biologists is leaping forward w/ @superbioai whose open-source platform transforms user-submitted pre-trained #AI models into no-code apps available for inference and retraining. Read the blog from @berkebuyukkucak & @ronjonnag https://t.co/F6L8rwDtVW

An old joke we love (and didn’t write). We know that your data is getting larger and algorithms more complex, and we got you covered. With https://t.co/AwTHgVp9Ya, you can run state-of-the-art biological models up to 50 times cheaper than a naive cloud implementation.

RELEASE DAY 🎉 Our scientist friends told us they were tired of manually writing code to explore data, and we listened! With https://t.co/AwTHgVp9Ya, explore your biomedical data in-depth with a single click, in seconds.

As for so many of you, 2021 has truly been a transformative year for Superbio. We were lucky to have met amazingly smart and relentlessly driven people, who through the examples of their own courage have made it possible to build our platform.

Making ML easier to use with drag and drop will accelerate science !

I’m chairing some some events @IETevents AI webinar series, which includes sessions on Opportunities, Challenges, Finance, Energy, Healthcare, Transport and Land, Air and Maritime. Please come and join me online! https://t.co/17szczdNFA #R42Group

Fragile X is a disease with few pharmaceutical options. From the community-led approach (@FRAXAresearch) to the use of AI to uncover existing and combination drugs this is a textbook case of how @healx may be able to help millions of people. A huge and hopeful step forward.

The powerful combination of #AI and drug redevelopment. Our Chief Medical Officer, Dr Anthony Hall, talks with @emmakbetuel @TechCrunch about our upcoming fragile X clinical trial. #rarediseases https://t.co/kHJahXP6YY

If you ever wondered what @R42group does, check out my @Medium post. Special shout out to ExpressCells & Matthew Handel, @SENISCA1 & @miRNAgirl and Ben Lee, @superbioai & @berkebuyukkucak, @SQZBiotech, and my friend & mentor @RonjonNag.

"To me this technology is going to replace about three or four other pieces of equipment that we traditionally use independent of each other. This one piece of equipment will replace those, at a fraction of the cost," #4glte @Verizon @McemaAl https://t.co/hH7CpycCWT

It was a great session this morning with my fellow panelists on #NewNowNext hosted by @RonjonNag sponsored by @LSciNation --- @SP8CEVCTeam 🧬🚀 @junaidmianrph